Glycophos Injection, Solution
Product Images NDC 65219-348

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Glycophos (NDC 65219-348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Gly0j 0001 01)

Chemical structure diagrams showing sodium glycerophosphate and its enantiomer, each depicted with sodium ions and water molecules in hydration. These structures represent the active ingredient in GLYCOPHOS injection solution at 216 mg/mL by Fresenius Kabi USA, LLC.*

FDA Label Image

Fresenius Kabi Logo (Gly0j 0001 02)

FDA Label Image

Package Label – Principal Display – Glycophos® (sodium Glycerophosphate Injection) 20 mL Vial Label (Gly0j 0001 03)

Label for Glycophos (sodium glycerophosphate injection) by Fresenius Kabi USA, LLC. The injection is 216 mg/mL strength in a 20 mL single-dose vial. The label highlights phosphorus 20 mmol/20 mL and sodium 40 mEq/20 mL concentrations and states the product is sterile, nonpyrogenic, preservative-free, and for intravenous use. It includes dilution and storage instructions along with a barcode and lot/expiration field.*

FDA Label Image

Package Label – Principal Display – Glycophos® (sodium Glycerophosphate Injection) 20 mL Tray Label (Gly0j 0001 04)

Glycophos (sodium glycerophosphate injection) 216 mg/mL, an intravenous solution by Fresenius Kabi USA, LLC. The label highlights phosphorus 20 mmol/20 mL and sodium 40 mEq/20 mL content, and notes it is sterile, nonpyrogenic, preservative-free. The package contains 25 single-dose 20 mL vials with caution to dilute before intravenous infusion.*

FDA Label Image

Package Label – Principal Display – Glycophos® (sodium Glycerophosphate Injection) 100 mL Vial Label (Gly0j 0001 05)

Label for Glycophos (sodium glycerophosphate injection) containing 216 mg/mL, a sterile, preservative-free intravenous solution. The label warns that it is a pharmacy bulk package not for direct infusion and must be diluted before intravenous infusion. It includes dosage components of phosphorus and sodium concentrations, storage instructions, and discard guidance. Manufactured by Fresenius Kabi USA, LLC in Lake Zurich, IL.*

FDA Label Image

Package Label – Principal Display – Glycophos® (sodium Glycerophosphate Injection) 100 mL Tray Label (Gly0j 0001 06)

Label for Glycophos (sodium glycerophosphate injection) by Fresenius Kabi USA, LLC. The injection strength is 216 mg/mL. It is a sterile, nonpyrogenic, preservative-free intravenous solution packaged as a pharmacy bulk package of 20 x 100 mL vials. The label highlights phosphorus and sodium content, dilution requirement before infusion, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.